Fascia Iliaca Compartment Block for Proximal-end Femur Fractures

NCT ID: NCT02696915

Last Updated: 2016-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fracture femur is a common injury which is associated with excruciating pain. Positioning for neuraxial blocks is always challenging because even slight overriding of the fracture ends is intensely painful .It can causing major patient distress which accompanied by well-known physiological sequelae such as sympathetic activation causing tachycardia, hypotension, and increased cardiac work that may compromise high-risk cardiac patients.

Fascia iliaca compartment block is highly effective in blocking lateral cutaneous nerve of the thigh and femoral nerve. Fascia iliaca compartment block is not only easy to perform but it is also associated with minimal risk as the local anesthetic is injected at a safe distance from the femoral artery and femoral nerve. It is always safe to perform the fascia iliaca compartment block prior to spinal anesthesia as the patient can respond during administration of the local anesthetic and can prevent intra-neuronal injections

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

On arrival to the pre-operative holding area half hour before the scheduled surgery. Patient will be connected to basal monitoring devices; pulse oximetry and non- invasive blood pressure. Fascia iliaca compartment block will be performed with the aid of ultrasound device in all cases.The injected local anesthetic solution will be prepared by a staff member who was not involved in the study) according to the randomization. After 20 minutes from the injection the investigators will assessed nerves that had been blocked.

On arrival to the operative theater, under complete aseptic technique spinal anesthesia will be carried out in the sitting position (if there is severe pain at positioning we will use lateral position) at space between L3-4 or L4-5 using a 25-gauge spinal quincke needle. After feeling the desired space, the needle will be advanced (paramedian approach) till free flow of cerebrospinal fluid dropped from the needle then 15 mg hyperbaric bupivacaine+20mic fentanyl will be injected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Proximal Femur Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Patients received ultrasound guided fascia iliaca compartment block using 40 ml of saline 0.9%. Then intrathecal medications will be administered.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Patients received ultrasound guided fascial iliaca compartment blockade using normal saline 0.9%, 40 ml

Ultrasound guided fascia iliaca compartment block

Intervention Type DEVICE

Ultrasound guided fascia iliaca compartment block

Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)

Intervention Type DRUG

Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms

Bupivacaine

Patients received ultrasound guided fascia iliaca compartment block using 40 ml of 0.25% bupivacaine. Then intrathecal medications will be administered.

Group Type ACTIVE_COMPARATOR

Bupivacaine

Intervention Type DRUG

Patients received ultrasound guided fascial iliaca compartment blockade using bupivacaine 0.25%, 40 ml

Ultrasound guided fascia iliaca compartment block

Intervention Type DEVICE

Ultrasound guided fascia iliaca compartment block

Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)

Intervention Type DRUG

Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Patients received ultrasound guided fascial iliaca compartment blockade using normal saline 0.9%, 40 ml

Intervention Type DRUG

Bupivacaine

Patients received ultrasound guided fascial iliaca compartment blockade using bupivacaine 0.25%, 40 ml

Intervention Type DRUG

Ultrasound guided fascia iliaca compartment block

Ultrasound guided fascia iliaca compartment block

Intervention Type DEVICE

Intrathecal medications (bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms)

Intrathecal hyperbaric bupivacaine (15 mg) in conjunction with fentanyl 20 micrograms

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologist physical status I to III
* Patients scheduled for fixation for proximal end femur fracture

Exclusion Criteria

* Patients refusal
* Morbid obese patients (BMI\>40)
* Bleeding diathesis
* Previous femoral bypass surgery
* Inguinal hernia
* Inflammation/infection over injection site
* Peripheral neuropathy
* Allergy to local anesthetics agents used.
* Severely altered consciousness level
* Psychiatric disorders
* Polytrauma
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Reem A El Sharkawy, MD

Role: STUDY_CHAIR

Lecturer of Anesthesia and Surgical Intensive Care

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura University Hospitals

Al Mansurah, DK, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

Reference Type DERIVED
PMID: 33238043 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS/811

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.